Tag: DCGI
-
Things you need to know about Favipiravir (Glenmark’s approved medicine for mild to moderate COVID-19 in India)
Glenmark’s Fabiflu is the first oral Favipiravir-approved medication for the treatment of COVID-19 and has been launched in few centers. The Drug Controller General of India approved the anti-viral for ‘restricted emergency use’ for treatment of mild to moderate cases, which accounts for a majority of COVID-19 infections. DCGI’s approval was based on Glenmark’s phase…